TP53 and myelodysplastic syndrome: Oestrogenic hormones significantly affect the levels or function of components of the p53 network, thus contributing to a higher prevalence of TP53 dysfunction in women with different types of cancers.24, 25 We found that myelodysplastic syndromes with germline DDX41 mutations2 had a strong preponderance in men.